The collaboration will focus on advancing the potential drug candidate—formerly known as VIS513—through Phase III clinical ...

SII partners with DNDi to develop affordable dengue treatment, aiming to save lives in LMICs and endemic countries.

Watch quick-thinking elephant rescue drowning gazelle with its trunk Rick Carlisle Provides Surprising Myles Turner Update ...

Hyderabad based vaccine maker Bharat Biotech International Limited (BBIL) has in-licensed a potential vaccine candidate for ...

The Serum Institute of India (SII), the world’s largest vaccine manufacturer and Drugs for Neglected Diseases initiative ...

Explore how India's 20-year product patent regime transformed its pharma industry from generics to innovation, the economic ...

Glenmark Pharmaceuticals to launch Brukinsa (zanubrutinib) in India after DCGI approval, offering treatment for five B-cell ...

Key Takeaways AI accelerates drug approvals in 2025 by streamlining clinical data analysis.Advanced AI tools reduce costs and time for new medicine development.

As India enters peak season for fungal infections, a breakthrough in natural medicine is making headlines: Skin Revive, a ...

A new study published in the Obesity Journal found that anti-obesity injections may have a lesser impact on weight loss in a real-world context compared to clinical trials, as patients tend to ...

Glenmark will introduce Brukinsa, a BTK inhibitor developed by BeOne Medicines, in India after DCGI approval to treat five ...

Lucknow: A recent study conducted at King George's Medical University (KGMU) found that piroxicam, a commonly used pain ...